Subjects Hospitalized With the 2009 Pandemic Influenza A (H1N1) Virus in a Respiratory Infection Unit: Clinical Factors Correlating With ICU Admission

References

1. 1.↵
   Centers for Disease Control and Prevention. People at high risk of developing flu-related complications. Updated 2012. http://www.cdc.gov/flu/about/disease/high_risk.htm. Accessed July 16, 2014.
2. 2.↵
   1. Lytras T,
   2. Theocharopoulos G,
   3. Tsiodras S,
   4. Mentis A,
   5. Panagiotopoulos T,
   6. Bonovas S

   , Influenza Surveillance Report Group. Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Euro Surveill 2009;14(29):pii 19275.
3. 3.↵
   1. Panagiotopoulos T,
   2. Bonovas S,
   3. Danis K,
   4. Iliopoulos D,
   5. Dedoukou X,
   6. Pavli A,
   7. et al

   . Cluster of new influenza A(H1N1) cases in travellers returning from Scotland to Greece–community transmission within the European Union? Euro Surveill 2009;14(21):pii 19226.
4. 4.↵
   1. Athanasiou M,
   2. Lytras T,
   3. Spala G,
   4. Triantafyllou E,
   5. Gkolfinopoulou K,
   6. Theocharopoulos G,
   7. et al

   . Fatal cases associated with pandemic influenza A (H1N1) reported in Greece. PLoS Curr 2010;2:RRN1194.

   OpenUrlPubMed
5. 5.
   Centers for Disease Control and Prevention (CDC). Deaths and hospitalizations related to 2009 pandemic influenza A (H1N1)–Greece, May 2009–February 2010. MMWR Morb Mortal Wkly Rep 2010;59(22):682–686.

   OpenUrlPubMed
6. 6.
   1. Sypsa V,
   2. Bonovas S,
   3. Tsiodras S,
   4. Baka A,
   5. Efstathiou P,
   6. Malliori M,
   7. et al

   . Estimating the disease burden of 2009 pandemic influenza A(H1N1) from surveillance and household surveys in Greece. PLoS ONE 2011;6(6):e20593.

   OpenUrlPubMed
7. 7.↵
   1. Nikolopoulos G,
   2. Bagos P,
   3. Lytras T,
   4. Bonovas S

   . An ecological study of the determinants of differences in 2009 pandemic influenza mortality rates between countries in Europe. PLoS ONE 2011;6(5):e19432.

   OpenUrlPubMed
8. 8.↵
   World Health Organization. Influenza (seasonal) Fact sheet No. 211. Updated 2014. www.who.int/mediacentre/factsheets/fs211/en/index.html. Accessed July 16, 2014.
9. 9.↵
   World Health Organization. Global alert and response (GAR). WHO recommendations for the post-pandemic period. Pandemic (H1N1) 2009 briefing note 23, 2010. http://www.who.int/csr/disease/swineflu/notes/briefing_20100810/en/index.html. Accessed July 16, 2014.
10. 10.↵
    Centers for Disease Control and Prevention. Interim guidance on case definitions to be used for investigations of novel influenza A (H1N1)v virus cases. http://www.cdc.gov/h1n1flu/casedef.htm. Accessed July 16, 2014.
11. 11.↵
    1. Ward CL,
    2. Dempsey MH,
    3. Ring CJ,
    4. Kempson RE,
    5. Zhang L,
    6. Gor D,
    7. et al

    . Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol 2004;29(3):179–188.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Charlson ME,
    2. Pompei P,
    3. Ales KL,
    4. MacKenzie CR

    . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373–383.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Smith JR,
    2. Rayner CR,
    3. Donner B,
    4. Wollenhaupt M,
    5. Klumpp K,
    6. Dutkowski R

    . Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Adv Ther 2011;28(11):927–959.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Van Kerkhove MD,
    2. Vandemaele KA,
    3. Shinde V,
    4. Jaramillo-Gutierrez G,
    5. Koukounari A,
    6. Donnelly CA,
    7. et al

    . Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011;8(7):e1001053.

    OpenUrlCrossRefPubMed
15. 15.
    1. Cardeñosa N,
    2. Rodés A,
    3. Follia N,
    4. Plasencia E,
    5. Lafuente S,
    6. Arias C,
    7. et al

    . Epidemiological analysis of severe hospitalized 2009 pandemic influenza A (H1N1) cases in Catalonia, Spain. Hum Vaccin 2011;7(Suppl):226–229.

    OpenUrlPubMed
16. 16.↵
    1. Fuhrman C,
    2. Bonmarin I,
    3. Paty AC,
    4. Duport N,
    5. Chiron E,
    6. Lucas E,
    7. et al

    . Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July–15 November 2009. Euro Surveill 2010;15(2); pii 19463.
17. 17.↵
    1. Hancock K,
    2. Veguilla V,
    3. Lu X,
    4. Zhong W,
    5. Butler EN,
    6. Sun H,
    7. et al

    . Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361(20):1945–1952.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.
    1. Lee VJ,
    2. Tay JK,
    3. Chen MI,
    4. Phoon MC,
    5. Xie ML,
    6. Wu Y,
    7. et al

    . Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 2010;28(42):6852–6857.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Iorio AM,
    2. Camilloni B,
    3. Lepri E,
    4. Neri M,
    5. Basileo M,
    6. Azzi A

    . Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (Winter 2003/04 and 2007/08). Proc Vaccinol 2011;4:50–58.

    OpenUrl
20. 20.↵
    1. Gill JR,
    2. Sheng ZM,
    3. Ely SF,
    4. Guinee DG,
    5. Beasley MB,
    6. Suh J,
    7. et al

    . Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010;134(2):235–243.

    OpenUrlPubMedWeb of Science
21. 21.↵
    1. Abdel-Ghafar AN,
    2. Chotpitayasunondh T,
    3. Gao Z,
    4. Hayden FG,
    5. Nguyen DH,
    6. et al

    Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008;358(3):261–273.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Echevarría-Zuno S,
    2. Mejía-Aranguré JM,
    3. Mar-Obeso AJ,
    4. Grajales-Muñiz C,
    5. Robles-Pérez E,
    6. González-León M,
    7. et al

    . Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009;374(9707):2072–2079.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Mertz D,
    2. Kim TH,
    3. Johnstone J,
    4. Lam PP,
    5. Science M,
    6. Kuster SP,
    7. et al

    . Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013;347:f5061.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Donaldson LJ,
    2. Rutter PD,
    3. Ellis BM,
    4. Greaves FE,
    5. Mytton OT,
    6. Pebody RG,
    7. Yardley IE

    . Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009;339:b5213.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Louie JK,
    2. Acosta M,
    3. Winter K,
    4. Jean C,
    5. Gavali S,
    6. Schechter R,
    7. et al

    . Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009;302(17):1896–902.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.
    1. Kumar A,
    2. Zarychanski R,
    3. Pinto R,
    4. Cook DJ,
    5. Marshall J,
    6. Lacroix J,
    7. et al

    . Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302(17):1872–1879.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Webb SA,
    2. Pettilä V,
    3. Seppelt I,
    4. Bellomo R,
    5. Bailey M,
    6. et al

    ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361(20):1925–1934.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Cordero E,
    2. Aydillo T,
    3. Fariñas MC,
    4. Paño-Pardo JR,
    5. Pachón J,
    6. Viasus D,
    7. et al

    . Immunosupressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2012;31(4):547–556.

    OpenUrlPubMed
29. 29.↵
    1. McKenna JJ,
    2. Bramley AM,
    3. Skarbinski J,
    4. Fry AM,
    5. Finelli L,
    6. Jain S,
    7. et al

    . Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection–United States, 2009. BMC Infect Dis 2013;13:57.

    OpenUrlPubMed
30. 30.↵
    1. de Miguel-Diez J,
    2. Carrasco-Garrido P,
    3. Hernández-Barrera V,
    4. Rodríguez-Rodríguez P,
    5. Puente-Maestu L,
    6. de Miguel AG,
    7. et al

    . Hospitalizations from pandemic influenza (pH1N1) infections among patients with asthma or COPD in Spain. J Infect 2012;65(1):95–98.

    OpenUrlPubMed
31. 31.↵
    1. Akinbami LJ,
    2. Moorman JE,
    3. Liu X

    . Asthma prevalence, health care use, and mortality: United States 2005-2009. Natl Health Stat Rep 2011;32:1–14. http://www.cdc.gov/nchs/data/nhsr/nhsr032.pdf. Accessed July 16, 2014.

    OpenUrl
32. 32.↵
    1. Nguyen-Van-Tam JS,
    2. Openshaw PJ,
    3. Hashim A,
    4. Gadd EM,
    5. Lim WS,
    6. Semple MG,
    7. et al

    . Risk factors for hospitalization and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009).Thorax 2010;65(7):645–651.

    OpenUrlAbstract/FREE Full Text
33. 33.
    1. Cullen G,
    2. Martin J,
    3. O'Donnell J,
    4. Boland M,
    5. Canny M,
    6. Keane E,
    7. et al

    . Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April–3 October 2009. Euro Surveill 2009;14(44):pii 19389.
34. 34.
    1. Denholm JT,
    2. Gordon CL,
    3. Johnson PD,
    4. Hewagama SS,
    5. Stuart RL,
    6. Aboltins C,
    7. et al

    . Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. MJA 2010;192(2):84–86.

    OpenUrlPubMed
35. 35.
    1. Santa-Olalla Peralta P,
    2. Cortes-García M,
    3. Vicente-Herrero M,
    4. Castrillo-Villamandos C,
    5. Arias-Bohigas P,
    6. Pachon-del Amo I,
    7. et al

    . Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April–December 2009. Euro Surveill 2010;15(38):pii 19667.
36. 36.↵
    1. Subramony H,
    2. Lai FY,
    3. Ang LW,
    4. Cutter JL,
    5. Lim PL,
    6. James L

    . An epidemiological study of 1348 cases of pandemic H1N1 influenza admitted to Singapore hospitals from July to Septembeer 2009. Ann Acad Med Singapore 2010;39(4):283–288.

    OpenUrlPubMedWeb of Science
37. 37.↵
    1. Martin SS,
    2. Hollingsworth CL,
    3. Norfolk SG,
    4. Wolfe CR,
    5. Hollingsworth JW

    . Reversible cardiac dysfunction associated with pandemic 2009 influenza A(H1N1). Chest 2010;137(5):1195–1197.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Kok J,
    2. Blyth CC,
    3. Foo H,
    4. Bailey MJ,
    5. Pilcher DV,
    6. Webb SA,
    7. et al

    . Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus. PLoS ONE 2013;8(2):e55631.

    OpenUrlPubMed
39. 39.↵
    1. Gutiérrez-Cuadra M,
    2. González-Fernández JL,
    3. Rodríguez-Cundin P,
    4. Fariñas-Álvarez C,
    5. San Juan MV,
    6. Parra JA,
    7. et al

    . Clinical characteristics and outcome of patients with pandemic 2009 influenza A(H1N1)v virus infection admitted to hospitals with different levels of health-care. Rev Esp Quimioter 2012;25(1):56–64.

    OpenUrlPubMed
40. 40.↵
    1. Cillóniz C,
    2. Ewig S,
    3. Menéndez R,
    4. Ferrer M,
    5. Polverino E,
    6. Reyes S,
    7. et al

    . Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect 2012;65(3):223–230.

    OpenUrlCrossRefPubMed
41. 41.↵
    1. Morens DM,
    2. Taubenberger JK,
    3. Fauci AS

    . Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198(7):962–970.

    OpenUrlAbstract/FREE Full Text
42. 42.↵
    1. Champunot R,
    2. Tanjatham S,
    3. Kerdsin A,
    4. Puangpatra P,
    5. Wangsai S,
    6. Treebuphachatsakul P,
    7. et al

    . Impact of pandemic influenza (H1N1) virus-associated community-acquired pneumonia among adults in a tertiary hospital in Thailand. Jpn J Infect Dis 2010;63(4):251–256.

    OpenUrlPubMed
43. 43.↵
    1. Wong SM,
    2. Bernui M,
    3. Shen H,
    4. Akerley BJ

    . Genome-wide fitness profiling reveals adaptations required by Haemophilus in coinfection with influenza A virus in the murine lung. Proc Natl Acad Sci USA 2013;110(38):15413–15418.

    OpenUrlAbstract/FREE Full Text
44. 44.↵
    1. Jamieson AM,
    2. Pasman L,
    3. Yu S,
    4. Gamradt P,
    5. Homer RJ,
    6. Decker T,
    7. Medzhitov R

    . Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 2013;340(6137):1230–1234.

    OpenUrlAbstract/FREE Full Text
45. 45.↵
    1. Viasus D,
    2. Paño-Pardo JR,
    3. Pachón J,
    4. Riera M,
    5. López-Medrano F,
    6. Payeras A,
    7. et al

    . Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A (H1N1) virus infection. Chest 2011;140(4):1025–1032.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Fiore AE,
    2. Fry A,
    3. Shay D,
    4. Gubareva L,
    5. Bresee JS,
    6. Uyeki TM

    , Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(1):1–24.

    OpenUrlPubMed
47. 47.
    1. Rodríguez A,
    2. Díaz E,
    3. Martín-Loeches I,
    4. Sandiumenge A,
    5. Canadell L,
    6. Díaz JJ,
    7. et al

    . Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother 2011;66(5):1140–1149.

    OpenUrlAbstract/FREE Full Text
48. 48.↵
    1. Kawai N,
    2. Ikematsu H,
    3. Tanaka O,
    4. Matsuura S,
    5. Maeda T,
    6. Yamauchi S,
    7. et al

    . Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008–2009 seasons. J Infect Chemother 2011;17(3):375–381.

    OpenUrlPubMed
49. 49.↵
    1. Trivellin V,
    2. Gandini V,
    3. Nespoli L

    . Low adherence to influenza vaccination campaigns: is the H1N1 virus pandemic to be blamed? Ital J Pediatr 2011;10:37:54.
50. 50.↵
    Centers for Disease Control and Prevention. Interim results: state-specific Influenza A (H1N1) 2009 monovalent vaccination coverage–United States, October 2009–January 2010. MMWR Morb Mortal Wkly Rep 2010;59(12):363–368.

    OpenUrlPubMed
51. 51.↵
    1. Tsiodras S,
    2. Sypsa V,
    3. Hatzakis A

    . The vaccination campaign against 2009 pandemic influenza A (H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic. Euro Surveill 2010;15(3):pii 19468.
52. 52.↵
    1. Sypsa V,
    2. Livanios T,
    3. Psichogiou M,
    4. Malliori M,
    5. Tsiodras S,
    6. Nikolakopoulos I,
    7. Hatzakis A

    . Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill 2009;14(49):pii 19437.